Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 23, 1998

View Archived Issues

Company Profile: Acacia Biosciences

Orally active enkephalinase-inhibitory prodrug reported by Dainippon

SmithKline Beecham presents new azetidinones for atherosclerosis

Inhibitors of prostaglandin biosynthesis prepared at Abbott

Enantiomers of trans-benz[e]indoles selective for D3 receptors

Lilly prepares compounds for controlling TxA2

Anti-H. pylori agents from Pfizer

Princeton and Lilly collaborate on development of inhibitors of folate enzymes

CRF antagonists patented by Pfizer

Irreversible HIV protease inhibitors under evaluation at LG Chemical

Novel bone resorption inhibitors from ADIR

Desmycosin derivatives a focus of research at Pliva

TNF-alpha inhibitors disclosed by Celgene

New telomerase inhibitors from Geron

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

New class of macrolides developed at Abbott

Ontogen describes novel MDR modulators

Efficacy and safety of oral contraception demonstrated in men

Abbott presents in vitro and in vivo efficacy data on tricyclic ketolides

Lexacalcitol: a vitamin D analogue with increased potency

Clinical results reported for Servier's MDR-reversing agent S-9788

HMR's new ketolides extensively discussed at conference this week

T Cell Sciences awarded SBIR grant for atherosclerosis vaccine

Viracept approved for marketing in E.U. member countries

Alkermes, Johnson & Johnson to codevelop novel formulation of erythropoietin

Boston Life Sciences to seek U.S. approval for Therafectin

Antegren meets development criteria in phase II trial

Quilimmune-P enters phase II

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...